BackNeuBase Therapeutics Overview

NeuBase Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for NBSE.

Quarterly EBIT

-$3.06M
↑ 60.34% YoY

As of Sep 30, 2023

Annual EBIT (TTM)

-$16.70M
↑ 50.47% YoY

Trailing 12 months ending Sep 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin